Cabazitaxel treatment in metastatic castration-resistant prostate cancer (mCRPC) clinical trials compared to usual care in CAPRI: An observational study in the Netherlands

H. M. Westgeest; M. Kuppen; A. J.M. van den Eertwegh; J. Van Moorselaar; N. Mehra; I. van Oort; A. C.M. van den Bergh; J. L. Coenen; K. K.H. Aben; R. Somford; R. de Wit; A. Bergman; J. Lavalaye; C. A. Uyl-de Groot; W. R. Gerritsen

doi:10.1093/annonc/mdy284.026

Cabazitaxel treatment in metastatic castration-resistant prostate cancer (mCRPC) clinical trials compared to usual care in CAPRI: An observational study in the Netherlands

H. M. Westgeest
, M. Kuppen
, A. J.M. van den Eertwegh
, J. Van Moorselaar
, N. Mehra
, I. van Oort
, A. C.M. van den Bergh
, J. L. Coenen
, K. K.H. Aben
, R. Somford
, R. de Wit
, A. Bergman
, J. Lavalaye
, C. A. Uyl-de Groot
, W. R. Gerritsen

Amphia ziekenhuis
Erasmus University Rotterdam
Radboud University Nijmegen
University of Groningen
Isala Clinics
IKNL
Canisius Wilhelmina Hospital
Netherlands Cancer Institute
St. Antonius Ziekenhuis

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	viii283-viii284
Journal	Annals of oncology : official journal of the European Society for Medical Oncology
Volume	29
DOIs	https://doi.org/10.1093/annonc/mdy284.026
Publication status	Published - 1 Oct 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1093/annonc/mdy284.026

Cite this

Westgeest, H. M., Kuppen, M., van den Eertwegh, A. J. M., Van Moorselaar, J., Mehra, N., van Oort, I., van den Bergh, A. C. M., Coenen, J. L., Aben, K. K. H., Somford, R., de Wit, R., Bergman, A., Lavalaye, J., Uyl-de Groot, C. A., & Gerritsen, W. R. (2018). Cabazitaxel treatment in metastatic castration-resistant prostate cancer (mCRPC) clinical trials compared to usual care in CAPRI: An observational study in the Netherlands. Annals of oncology : official journal of the European Society for Medical Oncology, 29, viii283-viii284. https://doi.org/10.1093/annonc/mdy284.026

@article{246e8670c5d54706947e38eb7ad3624d,

title = "Cabazitaxel treatment in metastatic castration-resistant prostate cancer (mCRPC) clinical trials compared to usual care in CAPRI: An observational study in the Netherlands",

author = "Westgeest, \{H. M.\} and M. Kuppen and \{van den Eertwegh\}, \{A. J.M.\} and \{Van Moorselaar\}, J. and N. Mehra and \{van Oort\}, I. and \{van den Bergh\}, \{A. C.M.\} and Coenen, \{J. L.\} and Aben, \{K. K.H.\} and R. Somford and \{de Wit\}, R. and A. Bergman and J. Lavalaye and \{Uyl-de Groot\}, \{C. A.\} and Gerritsen, \{W. R.\}",

year = "2018",

month = oct,

day = "1",

doi = "10.1093/annonc/mdy284.026",

language = "English",

volume = "29",

pages = "viii283--viii284",

journal = "Annals of oncology : official journal of the European Society for Medical Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

Westgeest, HM, Kuppen, M, van den Eertwegh, AJM , Van Moorselaar, J, Mehra, N, van Oort, I, van den Bergh, ACM, Coenen, JL, Aben, KKH, Somford, R, de Wit, R, Bergman, A, Lavalaye, J, Uyl-de Groot, CA & Gerritsen, WR 2018, 'Cabazitaxel treatment in metastatic castration-resistant prostate cancer (mCRPC) clinical trials compared to usual care in CAPRI: An observational study in the Netherlands', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 29, pp. viii283-viii284. https://doi.org/10.1093/annonc/mdy284.026

Cabazitaxel treatment in metastatic castration-resistant prostate cancer (mCRPC) clinical trials compared to usual care in CAPRI: An observational study in the Netherlands. / Westgeest, H. M.; Kuppen, M.; van den Eertwegh, A. J.M. et al.
In: Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, 01.10.2018, p. viii283-viii284.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Cabazitaxel treatment in metastatic castration-resistant prostate cancer (mCRPC) clinical trials compared to usual care in CAPRI

T2 - An observational study in the Netherlands

AU - Westgeest, H. M.

AU - Kuppen, M.

AU - van den Eertwegh, A. J.M.

AU - Van Moorselaar, J.

AU - Mehra, N.

AU - van Oort, I.

AU - van den Bergh, A. C.M.

AU - Coenen, J. L.

AU - Aben, K. K.H.

AU - Somford, R.

AU - de Wit, R.

AU - Bergman, A.

AU - Lavalaye, J.

AU - Uyl-de Groot, C. A.

AU - Gerritsen, W. R.

PY - 2018/10/1

Y1 - 2018/10/1

UR - https://www.scopus.com/pages/publications/85041196967

U2 - 10.1093/annonc/mdy284.026

DO - 10.1093/annonc/mdy284.026

M3 - Article

C2 - 32136651

SN - 0923-7534

VL - 29

SP - viii283-viii284

JO - Annals of oncology : official journal of the European Society for Medical Oncology

JF - Annals of oncology : official journal of the European Society for Medical Oncology

ER -

Westgeest HM, Kuppen M, van den Eertwegh AJM , Van Moorselaar J, Mehra N, van Oort I et al. Cabazitaxel treatment in metastatic castration-resistant prostate cancer (mCRPC) clinical trials compared to usual care in CAPRI: An observational study in the Netherlands. Annals of oncology : official journal of the European Society for Medical Oncology. 2018 Oct 1;29:viii283-viii284. doi: 10.1093/annonc/mdy284.026

Cabazitaxel treatment in metastatic castration-resistant prostate cancer (mCRPC) clinical trials compared to usual care in CAPRI: An observational study in the Netherlands

UN SDGs

Access to Document

Other files and links

Cite this